首页> 外国专利> LATHEO ENCODES A SUBUNIT OF THE ORIGIN OF RECOGNITION COMPLEX

LATHEO ENCODES A SUBUNIT OF THE ORIGIN OF RECOGNITION COMPLEX

机译:LATHEO编码识别复合体起源的一个子集

摘要

The present invention relates to isolated nucleic acid which encodes mammalian latheo protein (e.g., human). The present invention also relates to an isolated mammalian latheo protein (e.g., human). Also encompassed by the present invention are nucleic acid constructs, host cells, fusion proteins, antibodies and antisense nucleic acid. The present invention also relates to a method of producing a mammalian latheo protein. Also encompassed by the present invention are methods of identifying an agent that modulates (enhances, inhibits) interaction of latheo with a member of the origin recognition complex (e.g., ORC2, ORC4, ORC5, ORC6), a method of identifying an agent that modulates cell proliferation which results from latheo activity, a method of identifying sequence variants of latheo, a method of identifying an agent for use in the treatment of cancer, a method of identifying an agent to treat defects in synaptic function associated with a defective latheo and a method of identifying an agent to treat a cognitive dysfunction associated with latheo. Agents identified by the methods are also encompassed. The present invention also relates to methods of treating cancer, a defect in synaptic plasticity associated with a defective latheo and cognitive dysfunction associated with a defective latheo.
机译:本发明涉及编码哺乳动物车床蛋白(例如人)的分离的核酸。本发明还涉及分离的哺乳动物车床蛋白(例如人)。本发明还包括核酸构建体,宿主细胞,融合蛋白,抗体和反义核酸。本发明还涉及产生哺乳动物车床蛋白的方法。本发明还包括鉴定调节(增强,抑制)车床与来源识别复合体成员(例如,ORC2,ORC4,ORC5,ORC6)的相互作用的试剂的方法,鉴定鉴定可调节药物的试剂的方法。由Latheo活性引起的细胞增殖,鉴定Latheo序列变异的方法,鉴定用于治疗癌症的药物的方法,鉴定治疗与Latheo缺陷相关的突触功能缺陷的药物的方法以及确定治疗与车床相关的认知功能障碍的药物的方法。还包括通过该方法鉴定的试剂。本发明还涉及治疗癌症,与车床缺陷有关的突触可塑性缺陷和与车床缺陷有关的认知功能障碍的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号